Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Pan-3C Protease Inhibitor Rupintrivir Binds SARS-CoV-2 Main Protease in a Unique Binding Mode

Journal Article · · Biochemistry

Not provided.

Research Organization:
Brookhaven National Lab. (BNL), Upton, NY (United States). National Synchrotron Light Source II (NSLS-II)
Sponsoring Organization:
USDOE Office of Science (SC)
DOE Contract Number:
SC0012704
OSTI ID:
1981812
Journal Information:
Biochemistry, Vol. 60, Issue 39; ISSN 0006-2960
Publisher:
American Chemical Society (ACS)
Country of Publication:
United States
Language:
English

References (29)

Human viruses: discovery and emergence journal October 2012
Epidemiological dynamics of enterovirus D68 in the United States and implications for acute flaccid myelitis journal March 2021
An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus journal October 2003
Discovery and Selection of TMC114, a Next Generation HIV-1 Protease Inhibitor § journal March 2005
HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK journal September 2016
TMC114, a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor Active against Protease Inhibitor-Resistant Viruses, Including a Broad Range of Clinical Isolates journal May 2005
Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease journal March 2021
Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2 journal October 2020
Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture journal May 2021
Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes journal September 1999
Conservation of Amino Acids in Human Rhinovirus 3C Protease Correlates with Broad-Spectrum Antiviral Activity of Rupintrivir, a Novel Human Rhinovirus 3C Protease Inhibitor journal February 2005
Phase II, Randomized, Double-Blind, Placebo-Controlled Studies of Ruprintrivir Nasal Spray 2-Percent Suspension for Prevention and Treatment of Experimentally Induced Rhinovirus Colds in Healthy Volunteers journal November 2003
Pharmacokinetics and Safety of an Antirhinoviral Agent, Ruprintrivir, in Healthy Volunteers journal February 2002
Rupintrivir is a promising candidate for treating severe cases of Enterovirus-71 infection journal January 2010
Inhibition of the severe acute respiratory syndrome 3CL protease by peptidomimetic α,β-unsaturated esters journal September 2005
Crystal Structures of Enterovirus 71 3C Protease Complexed with Rupintrivir Reveal the Roles of Catalytically Important Residues journal August 2011
The SARS-CoV-2 main protease as drug target journal September 2020
Proton-Coupled Conformational Activation of SARS Coronavirus Main Proteases and Opportunity for Designing Small-Molecule Broad-Spectrum Targeted Covalent Inhibitors journal December 2020
Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188 journal January 2021
XDS journal January 2010
Phaser crystallographic software journal July 2007
3C Protease of Enterovirus 68: Structure-Based Design of Michael Acceptor Inhibitors and Their Broad-Spectrum Antiviral Effects against Picornaviruses journal April 2013
Coot model-building tools for molecular graphics journal November 2004
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
electronic Ligand Builder and Optimization Workbench ( eLBOW ): a tool for ligand coordinate and restraint generation journal September 2009
Free R value: a novel statistical quantity for assessing the accuracy of crystal structures journal January 1992
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids journal May 2007
The Protein Data Bank journal January 2000
Announcing the worldwide Protein Data Bank journal December 2003